Literature DB >> 24774728

Prognostic impact of chronic total occlusion in a nonculprit artery in patients with acute myocardial infarction undergoing primary angioplasty.

Albert Ariza-Solé1, Luis Teruel2, Andrea di Marco3, Victòria Lorente3, José C Sánchez-Salado3, Guillermo Sánchez-Elvira2, Rafael Romaguera2, Josep Gómez-Lara2, Joan A Gómez-Hospital2, Angel Cequier2.   

Abstract

INTRODUCTION AND
OBJECTIVES: The prognostic value of chronic total occlusion in nonculprit coronary arteries in patients with myocardial infarction undergoing primary angioplasty remains controversial. Several publications have described different methodologies and conflicting findings. In addition, causes of death were not reported. Our aim is to analyze the prognostic impact of chronic total occlusion in nonculprit coronary arteries and the role of left ventricular ejection fraction in this analysis.
METHODS: Prospective inclusion of consecutive patients with ST-segment elevation myocardial infarction who underwent primary angioplasty. We recorded baseline characteristics, in-hospital clinical course, and mortality and its causes during follow-up. We assessed the impact of chronic total occlusion on mortality using Cox regression analysis.
RESULTS: Chronic total occlusion in nonculprit arteries was present in 125 of 1176 patients (10.6%); in 79 of these 125 patients, chronic total occlusion was present in the proximal segments. The mean follow-up was 339 days; 64 (5.8%) patients died during the first 6 months. Patients with chronic total occlusions had more comorbidities, poorer ventricular function, and higher mortality (hazard ratio=2.79; 95% confidence interval, 1.71-4.56). Chronic total occlusion was also associated with noncardiac death (hazard ratio=3.83; 95% confidence interval, 2.10-7.01). Chronic total occlusion in proximal segments was associated with both cardiac (hazard ratio=3.22; 95% confidence interval, 1.42-7.30) and noncardiac deaths (hazard ratio=3.43; 95% confidence interval, 1.67-7.06). The multivariate analysis performed without including left ventricular ejection fraction showed a significant association between chronic total occlusion and mortality. However, when left ventricular ejection fraction was included in the analysis, this association was nonsignificant (hazard ratio=1.76; 95% confidence interval, 0.85-3.65; P=.166).
CONCLUSIONS: Chronic total occlusion in this clinical setting identified patients at higher risk with more comorbidities and higher mortality, but did not behave as an independent predictor of mortality when left ventricular ejection fraction was included in the analysis.
Copyright © 2013 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Angioplastia primaria; Chronic total occlusion; Infarto de miocardio; Myocardial infarction; Oclusión total crónica; Primary angioplasty; Prognosis; Pronóstico

Mesh:

Year:  2014        PMID: 24774728     DOI: 10.1016/j.rec.2013.08.012

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  4 in total

1.  Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed.

Authors:  Alfredo Bardají; Gil Bonet
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Prognostic factors of in-hospital mortality in all comers with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Songsak Kiatchoosakun; Chaiyasith Wongwipaporn; Burabha Pussadhamma
Journal:  Heart Asia       Date:  2016-06-14

3.  AMI and Anabolic-Androgenic Steroids: Case Report with Systematic Review.

Authors:  Eliana M Mustafa; Idiberto José Zotarelli Filho; Victor R R Ferreira; Sofia Braile Sabino; Giovanni B Sternieri; Luiza B Verdi; Cibele O V Queiroz; Bethina C Sbardellini; Maria C V B Braile-Sternieri
Journal:  Curr Cardiol Rev       Date:  2021

4.  The 11-Year Prognostic Impact of Chronic Total Occlusion in the Noninfarct-Related Coronary Artery on Patients with Acute Myocardial Infarction.

Authors:  Xuanqi An; Jingang Yang; Kefei Dou; Yuejin Yang
Journal:  J Interv Cardiol       Date:  2021-03-17       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.